NgR1 binding to reovirus reveals an unusual bivalent interaction and a new viral attachment protein
Open Access
- 5 June 2023
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (24)
Abstract
Nogo-66 receptor 1 (NgR1) binds a variety of structurally dissimilar ligands in the adult central nervous system to inhibit axon extension. Disruption of ligand binding to NgR1 and subsequent signaling can improve neuron outgrowth, making NgR1 an important therapeutic target for diverse neurological conditions such as spinal crush injuries and Alzheimer’s disease. Human NgR1 serves as a receptor for mammalian orthoreovirus (reovirus), but the mechanism of virus–receptor engagement is unknown. To elucidate how NgR1 mediates cell binding and entry of reovirus, we defined the affinity of interaction between virus and receptor, determined the structure of the virus–receptor complex, and identified residues in the receptor required for virus binding and infection. These studies revealed that central NgR1 surfaces form a bridge between two copies of viral capsid protein σ3, establishing that σ3 serves as a receptor ligand for reovirus. This unusual binding interface produces high-avidity interactions between virus and receptor to prime early entry steps. These studies refine models of reovirus cell-attachment and highlight the evolution of viruses to engage multiple receptors using distinct capsid components.Keywords
Funding Information
- HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (T32 AI007281)
- HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (R01 AI038296)
- HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (R01 AI118887)
- HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (R01 AI174526)
- Pitt | UPMC | Children’s Hospital of Pittsburgh (N/A)
- Heinz Endowments (N/A)
- AUL | Université Catholique de Louvain (N/A)
- Fonds De La Recherche Scientifique - FNRS (N/A)
- EC | European Research Council (758224)
- Fonds De La Recherche Scientifique - FNRS (CR-2019S-01)
This publication has 93 references indexed in Scilit:
- AMIGO3 Is an NgR1/p75 Co-Receptor Signalling Axon Growth Inhibition in the Acute Phase of Adult Central Nervous System InjuryPLOS ONE, 2013
- Role of myelin-associated inhibitors in axonal repair after spinal cord injuryExperimental Neurology, 2012
- NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycansNature Neuroscience, 2012
- Recovery from chronic spinal cord contusion after nogo receptor interventionAnnals of Neurology, 2011
- The Structural Biology of Toll-like ReceptorsStructure, 2011
- Crystal structure of the Nogo‐receptor‐2Protein Science, 2011
- An improved reverse genetics system for mammalian orthoreovirusesVirology, 2010
- Junctional Adhesion Molecule-A Is Required for Hematogenous Dissemination of ReovirusCell Host & Microbe, 2009
- Multiple receptors involved in human rhinovirus attachment to live cellsProceedings of the National Academy of Sciences, 2008
- A Plasmid-Based Reverse Genetics System for Animal Double-Stranded RNA VirusesCell Host & Microbe, 2007